Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01401894 · ClinicalTrials.gov registry record
Perception Prognosis, Goals of Treatment, and Communication
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 50
- Enrollment target
NCT01401894: Completed study, sponsored by Massachusetts General Hospital.
NCT01401894 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01401894 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this research study is to assess what the participant understands about their illness, prognosis, the goals of the cancer treatment and their communication with their oncology providers. This study will help us to figure out how the investigators can improve how other patients understand their illness and goals of treatment and help us improve communication with their doctors. This research is being done because there is not a lot of information on how much patients understand about their illness and prognosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01401894
The ClinicalTrials.gov registry entry for NCT01401894 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01401894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01401894 about?
NCT01401894 is a clinical study titled "Perception Prognosis, Goals of Treatment, and Communication". The purpose of this research study is to assess what the participant understands about their illness, prognosis, the goals of the cancer treatment and their communication with their oncology providers. This study will help us to figure out how the investigators can improve how other patients underst...
What is the current status of trial NCT01401894?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2010-10. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01401894?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.